Life Technologies

Life Technologies establishes international influenza network

Friday, February 1, 2013 01:14 PM

Life Technologies, a global biotechnology company, has established the Global Influenza Network, a partnership including scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development.

More... »

Life Technologies acquires Compendia Bioscience

Tuesday, October 9, 2012 02:54 PM

Carlsbad, Calif.-based Life Technologies is acquiring Compendia Bioscience, a cancer bioinformatics company helping the pharmaceutical industry to identify novel gene targets for drug discovery and development.

More... »

CollabRx partners with Life Technologies in molecular diagnostics

Friday, October 5, 2012 08:00 AM

CollabRx, a provider of cloud-based expert systems to inform health care decision-making, has formed a multi-year partnership agreement with Life Technologies, global biotechnology tools company for development and commercialization of CollabRx technology and content resources to be used in conjunction with Life Technologies' global cancer diagnostics development and its laboratory developed test services business.

More... »

Knome introduces knoSYS100, first plug-and-play human genome interpretation system

Friday, September 28, 2012 12:10 PM

Knome, a Cambridge, Mass.-based provider of human genome interpretation systems and services, has launched its knoSYS100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes.

More... »

Life Technologies, BMS to partner on diagnostics development

Monday, September 17, 2012 01:17 PM

Life Technologies, a global biotech, has entered into a master development agreement with Bristol-Myers Squibb for current and future companion diagnostics projects.

More... »

Thirty teams compete to interpret three families' genomes

Monday, August 20, 2012 12:08 PM

In a contest led by Boston Children's Hospital, 30 teams from around the world are vying to interpret the DNA sequences of three children with rare conditions whose cause remains a mystery—with the goal of establishing "best practices" for interpreting genomic data.

More... »

New York Genome Center launches innovation center

Thursday, August 2, 2012 11:42 AM

New York Genome Center (NYGC), a non-profit engaged in a cooperative effort to transform medical research and clinical care, has launched its innovation center, which will provide access to new sequencing technologies and foster collaboration among NYGC’s institutional founding members (IFMs) and technology collaborators.

More... »

Baxter to acquire Synovis for $260 million

Tuesday, December 13, 2011 11:30 AM

Baxter International and Synovis Life Technologies have reported a definitive agreement for Baxter to acquire Synovis, a provider of biological and mechanical products for soft tissue repair used in a variety of surgical procedures. The acquisition complements and will expand the portfolio of Baxter's regenerative medicine and biosurgery franchise, which includes a number of devices and biological products for hemostasis, tissue sealing and adherence.

More... »

Life Technologies, GSK ink cancer research agreement

Wednesday, October 26, 2011 10:55 AM

Life Technologies has signed an agreement with GlaxoSmithKline to develop a diagnostic to be used as a companion test with a GSK candidate cancer immunotherapy. Life will develop a qPCR-based molecular diagnostic assay for GSK's MAGE-A3 cancer immunotherapy candidate designed to identify patients likely to benefit from the immunotherapy.

More... »

FDA grants 510K clearance to Life Technologies

Thursday, March 17, 2011 12:04 PM

Life Technologies said it has received FDA 510K clearance for StemProR MSC SFM—a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the U.S.

More... »